SS
Steve Seedhouse Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $91 |
144%
upside
| 1 | +8.9% |
0
%
| 4 Mar ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $266 |
53%
upside
| 1 | +23% |
0
%
| 3 Mar ‘26 3 days ago |
|
|
|
Overweight
Initiated
| $40 |
47%
upside
| 1 | +13% |
0
%
| 19 Feb ‘26 15 days ago |
|
|
|
Overweight
Maintained
| $41 |
213%
upside
| 2 | +47% |
0
%
| 5 Feb ‘26 29 days ago |
|
|
|
Overweight
Upgraded
| $21 |
96%
upside
| 1 | +29% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $35 |
75%
upside
| 1 | -4.7% |
0
%
| 13 Jan ‘26 1 month ago |
|